CaryAPresantMD

Hematologic Oncology

Professor of Medicine, USC School of Medicine

Overview of Dr. Presant

Dr. Cary Presant is an oncologist in West Covina, CA and is affiliated with multiple hospitals in the area, including City of Hope's Helford Clinical Research Hospital, Emanate Health Inter-Community Hospital, and Emanate Health Foothill Presbyterian Hospital. He received his medical degree from University at Buffalo, School of Medicine and Biomedical Sciences and has been in practice 51 years. Dr. Presant accepts several types of health insurance, listed below. He is one of 18 doctors at Emanate Health Inter-Community Hospital and one of 9 doctors at Emanate Health Foothill Presbyterian Hospital who specialize in Oncology.

Office
1250 S Sunset Ave
Suite 303
West Covina, CA 91790
Book by Phone(626) 269-6807
Fax(626) 856-5853
Is this information wrong?

Education & Training

Washington University - Barnes-Jewish HospitalResidency, Internal Medicine, 1969 - 1970
New York Presbyterian Hospital - Columbia CampusInternship, Internal Medicine, 1966 - 1967
University at Buffalo, School of Medicine and Biomedical SciencesClass of 1966

Certifications & Licensure

CA State Medical License 1970 - 2022
MO State Medical License 1969 - 2022
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology

Awards, Honors, & Recognition

Top Doctors:LA Area Castle Connolly, 2013
CMS Meaningful Use Stage 1 Certification ARIA Medical Oncology EMR, Varian Medical Systems, 2013
Top Doctors:Southern California Castle Connolly, 2012
Fellow (FASCO) American Society of Clinical Oncologists, 2007
Super Doctor SuperDoctors.com
Join now to see all

Clinical Trials

Microculture Kinetic (MiCK) Apoptosis Test Results With Drug Treatment Results in Cancer Patients Start of enrollment: 2008 Dec 01Presant, C.,Davidson, D.,Marcet, J.E.,Rogers, K.,Jr., L.J.,Lawson, L.,Jelsma, P.F.,Bluth, R.F.,Michaelson, R.D.,Rajurkar, S.P.
Application of the Microculture Kinetic (MiCK) Assay for Apoptosis to Drug Testing Sensitivity of Solid Tumors Start of enrollment: 2006 Sep 01Presant, C.,Rogers, K.,Whitworth, P.,Zweibach, A.
Testing Drug Sensitivity of Ovarian, Fallopian and Primary Peritoneal Adenocarcinomas Start of enrollment: 2006 Mar 01Presant, C.
Use of the MiCK Assay for Apoptosis to Predict Complete Remission in Acute Myeloid Leukemia Start of enrollment: 2006 Jan 01Presant, C.

Publications & Presentations

PubMed

Phase II study of neratinib in older adults with HER2 amplified or HER2/3 mutated metastatic breast cancer.
Yuan Yuan, Jin Sun Lee, Susan E. Yost, Tracey Stiller, M. Suzette Blanchard, Simran Padam, Vani Katheria, Heeyoung Kim, Can-Lan Sun, Aileen Tang, Norma Martinez, Niki ...> ;Journal of Geriatric Oncology. 2021 Mar 1
Implementing Lung Cancer Screening and Prevention in Academic Centers, Affiliated Network Offices and Collaborating Care Sites.
Cary A. Presant, Ravi Salgia, Prakash Kulkarni, Brian L. Tiep, Shamel Sanani, Benjamin Leach, Kimlin Tam Ashing, Jossie Sandoval, Mina S. Sedrak, Shana Landau, Sophia ...> ;Journal of Clinical Medicine. 2020 Jun 11
4 citations
Strategies to improve participation of older adults in cancer research
Jennifer Liu, Eutiquio Gutierrez, Abhay Tiwari, Simran Padam, Daneng Li, William Dale, Sumanta K. Pal, Daphne Stewart, Shanmugga Subbiah, Linda D. Bosserman, Cary A. P...> ;Journal of Clinical Medicine. 2020 May 22
2 citations
Application of a Drug-Induced Apoptosis Assay to Identify Treatment Strategies in Recurrent or Metastatic Breast Cancer
Linda Bosserman, Karl Rogers, Carl Rogaston Willis, Dirk C. Davidson, Pat Whitworth, Misagh Karimi, G. Upadhyaya, James Rutledge, Allan Hallquist, Mathieu Perree, Cary...> ;PLOS ONE. 2015 May 29
5 citations
Correlation of the microculture-kinetic drug-induced apoptosis assay with patient outcomes in initial treatment of adult acute myelocytic leukemia.
Stephen A. Strickland, Anastasios Raptis, Allan Hallquist, James Rutledge, Michael R. Chernick, Mathieu Perree, Mahsa S. Talbott, Cary A. Presant> ;Leukemia & Lymphoma. 2013 Mar 1
2 citations
Correlation of drug-induced apoptosis assay results with oncologist treatment decisions and patient response and survival.
Linda Bosserman, Swapnil Rajurkar, Karl Rogers, Dirk C. Davidson, Michael R. Chernick, Allan Hallquist, Debbee Malouf, Cary A. Presant> ;Cancer. 2012 Oct 1
9 citations
The Microculture-Kinetic (MiCK) Assay: The Role of a Drug-Induced Apoptosis Assay in Drug Development and Clinical Care
Linda D. Bosserman, Franklyn G Prendergast, Roy S. Herbst, Martin Fleisher, Emery M. Salom, Steven Strickland, Anastasios Raptis, Allan Hallquist, Mathieu Perree, Swap...> ;Cancer Research. 2012 Aug 15
7 citations
Correlation of pretreatment drug induced apoptosis in ovarian cancer cells with patient survival and clinical response
Emery M. Salom, Manuel Penalver, Howard D. Homesley, Matthew Burrell, Audrey Garrett, Cary A. Presant, James Rutledge, Michael R. Chernick, Allan Hallquist, Mathieu Pe...> ;Journal of Translational Medicine. 2012 Aug 8
Psychosocial (PS) resilience augmenting strategies (RAS) in patients (PT) with cancer (CA) post-traumatic growth (PTG): A pilot study for personalized survivorship imp...
Presant CA, Hartono S, Upadhyaya GH> ;J. Clin. Oncol.. 2011-05-20
A Copay Foundation Assistance Support Program for Patients Receiving Intravenous Cancer Therapy
Swapnil Rajurkar, Cary A. Presant, Linda D. Bosserman, Wendy McNatt> ;Journal of Oncology Practice. 2011 Mar 1
9 citations
Endometrial carcinoma in vitro chemosensitivity testing of single and combination chemotherapy regimens using the novel microculture kinetic apoptosis assay: implicati...
Karen S. Ballard, Howard D. Homesley, Charles A. Hodson, Cary A. Presant, James Rutledge, Allan Hallquist, Mathieu Perree> ;Journal of Gynecologic Oncology. 2010 Mar 1
A novel copay foundation assistance support program for patients receiving cancer therapy in cancer centers.
Rajurkar SP, Presant C, Bosserman L, McNatt W> ;J. Clin. Oncol.. 2009-05-20
Patient (PT) participation and disaster (D) agency (AG) coordination for oncology (ONC) PT D preparedness (PREP): Analysis of the Great Southern California Shake Out (...
Moss RA, Presant C, Lamb M> ;J. Clin. Oncol.. 2009-05-20
The value of personalized treatment (Rx) planning (PTP): Cost savings (sav) by the Microculture Kinetic (MiCK) chemosensitivity (CS) assay, evidence from a large Ameri...
Latimer RG, Presant CA, Hallquist AE, Perree M, Agapitos D> ;J. Clin. Oncol.. 2009-05-20
Chemosensitivity (CS) of patient (pt) breast cancer (BrCa) cells in vitro: Correlation with prior chemotherapy (CT) and implications for personalized treatment planning.
Whitworth PW, Presant CA, Rutledge J, Hallquist A, Perree M, Agapitos D> ;J. Clin. Oncol.. 2009-05-20
Patterns of metastatic (met) disease sites in breast cancer (BrCa): Implications for availability of fresh tumor tissue (FTT) for personalized BrCa treatment (Rx) plan...
Presant CA, Bosserman L, Howard F, Emilio B> ;J. Clin. Oncol.. 2009-05-20
Treatment (T) guideline (G) development and implementation (I) in community (COMM) practice (P): Experience of the cancer centers of excellence (CCE) network and its c...
Schnell FM, Bosserman LD, Ebrahimi B, Presant CA, Bergstrom K> ;J. Clin. Oncol.. 2008-05-20
Patient (pt) evaluation of the Oncology Pt Emergency Network (OPEN): Implications for oncology practices.
Presant CA, Hartono S, Ampudia M, Howard F> ;J. Clin. Oncol.. 2008-05-20
Compliance (COMP) with colon cancer (CoC) national guidelines (NG) for chemotherapy (CT) by implementing electronic medical records (EMR).
Ebrahimi B, Presant CA, Bosserman LD, Horns R, Vakil M, Upadhyaya G, Yeon C, Howard F, McNatt W, Emilio B> ;J. Clin. Oncol.. 2008-05-20
74 citations
Aromatase Inhibitor–Associated Arthralgia and/or Bone Pain: Frequency and Characterization in Non–Clinical Trial Patients
Cary A. Presant, Linda D. Bosserman, Traci Young, Mayank Vakil, Richard Horns, G. Upadhyaya, Behnam Ebrahimi, Christina Yeon, Frank Howard> ;Clinical Breast Cancer. 2007 Oct 1
A conversation with Cary Presant.
Cary Presant> ;Managed care interface. 2007 Sep 1
Development of a model emergency oncology response system (EORS): The California oncology emergency master plan (COEMP).
Moss R, Yu P, Presant C, Gonzalez J, Lamb M, Tucker S> ;J. Clin. Oncol.. 2006-06-20
Aromatase inhibitor (AI)-associated arthralgia (A) and bone pain (BP): Frequency and characterization in clinical practice.
Presant CA, Kelly C, Bosserman L, Upadhyaya G, Vakil M, Horns R, Ebrahimi B, Yeon C, Howard F, Rios A> ;J. Clin. Oncol.. 2006-06-20
Pharmacokinetic (PK) and pharmacodynamic (PD) study of the effect of imatinib (Ima) on tumor (T) vascularity (V) and on gemcitabine (Ge) uptake (U) using non-invasive ...
Wolf W, Presant CA, Waluch V, Chen EJ> ;J. Clin. Oncol.. 2006-06-20
4 citations
Effects of weekly paclitaxel or paclitaxel plus carboplatin on functionality and symptoms of geriatric patients with cancer as measured by a brief geriatric oncology m...
Cary A. Presant, Erin Thompson, Brian LeBerthon, R N Lori Vergara, R N Priscilla McGowen> ;Cancer. 2005 Jun 15
Join now to see all

Books/Book Chapters

Surviving American Medicine
Cary Presant2012

Press Mentions

12 Foods Cancer Docs Try to Never EatNovember 13th, 2018
The Big Sick Star Shana Solomon Receives Home Award from Dr. Cary PresantFebruary 26th, 2018
Finding the on-Ramp to Clinical Trial OfferingsNovember 6th, 2017
Join now to see all

Grant Support

Monitoring Of Drug Therapy In Breast CancerNational Cancer Institute1994–1996
Central LOS Angeles Community Clinical Oncology ProgramNational Cancer Institute1988–1993
Community Clinical Oncology ProgramNational Cancer Institute1987–1990

Professional Memberships

American Society of Clinical Oncology - ASCO
Fellow

Hospital Affiliations

City of Hope's Helford Clinical Research HospitalDuarte, California
Emanate Health Inter-Community HospitalCovina, California
Emanate Health Foothill Presbyterian HospitalGlendora, California

Insurance Accepted

Aetna Choice POS II
BCBS Blue Card PPO
BCBS California CaliforniaCare HMO
BCBS California PowerSelect HMO
BCBS California PPO
Blue Shield CA Local Access Plus HMO
Blue Shield California HMO
Blue Shield California PPO
CIGNA HMO
CIGNA Open Access
CIGNA PPO
First Health PPO
Great West PPO
Health Net California Large Group PPO
Humana ChoiceCare Network PPO
Multiplan PHCS PPO
Multiplan PHCS PPO - Kaiser
Multiplan PPO
Pacificare HMO
United Healthcare - Direct Choice Plus POS
United Healthcare - Direct Options PPO
Please verify your coverage with the provider's office directly when scheduling an appointment